Reviva Pharmaceuticals Holdings Inc (RVPH): Next-Year EPS Estimate 27.95%
As of 2026-05-14, Reviva Pharmaceuticals Holdings Inc (RVPH) has a next-year EPS growth estimate of 27.95%.
On 2026-05-14, analyst consensus for RVPH's next-year EPS growth shifted from 35.69% to 27.95% — a negative change of 7.74 percentage points. Current-year growth is projected at 70.62%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 27.95%
- EPS growth this year
- 70.62%
- EPS next quarter (est)
- -$0.48
- Last price
- $0.35
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-14 | 27.95% | 70.62% | -$0.48 | $0.35 |
| 2026-05-13 | 35.69% | 69.71% | -$0.33 | $0.37 |
| 2026-05-12 | 35.69% | 69.71% | -$0.33 | $0.80 |
| 2026-05-11 | 35.69% | 69.71% | -$0.33 | $0.80 |
| 2026-05-10 | 35.69% | 69.71% | -$0.33 | $0.86 |
| 2026-05-07 | 35.69% | 69.71% | -$0.33 | $0.86 |
| 2026-05-06 | 35.69% | 69.71% | -$0.33 | $0.88 |
| 2026-05-05 | 35.69% | 69.71% | -$0.33 | $0.82 |
| 2026-05-04 | 35.69% | 69.71% | -$0.33 | $0.84 |
| 2026-05-03 | 35.69% | 69.71% | -$0.33 | $0.88 |
| 2026-04-30 | 35.69% | 69.71% | -$0.33 | $0.87 |
| 2026-04-29 | 35.69% | 69.71% | -$0.33 | $0.87 |
| 2026-04-28 | 35.69% | 69.71% | -$0.33 | $0.88 |
| 2026-04-27 | 35.69% | 69.71% | -$0.33 | $0.88 |
| 2026-04-26 | 35.69% | 69.71% | -$0.33 | $0.90 |
| 2026-04-24 | 35.69% | 69.71% | -$0.33 | $0.90 |
| 2026-04-23 | 58.08% | 58.82% | -$0.82 | $0.89 |
| 2026-04-22 | 58.08% | 58.82% | -$0.82 | $0.93 |
| 2026-04-21 | 58.08% | 58.82% | -$0.82 | $0.91 |
| 2026-04-20 | 58.08% | 58.82% | -$0.82 | $0.91 |
| 2026-04-19 | 58.08% | 58.82% | -$0.82 | $0.85 |
| 2026-04-16 | 58.08% | 58.82% | -$0.82 | $0.87 |
| 2026-04-15 | 59.70% | 57.17% | -$0.78 | $0.89 |
| 2026-04-14 | 59.70% | 57.17% | -$0.78 | $0.86 |
| 2026-04-13 | 59.70% | 57.17% | -$0.78 | $0.87 |
| 2026-04-12 | 59.70% | 57.17% | -$0.78 | $0.77 |
| 2026-04-10 | 59.70% | 57.17% | -$0.78 | $0.77 |
| 2026-04-09 | 59.70% | 57.17% | -$0.78 | $0.85 |
| 2026-04-08 | 59.70% | N/A | -$0.78 | $0.79 |
| 2026-04-07 | 31.23% | N/A | -$1.05 | $0.78 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Reviva Pharmaceuticals Holdings Inc's next-year EPS growth estimate?▾
As of 2026-05-14, Reviva Pharmaceuticals Holdings Inc (RVPH) has a next-year EPS growth estimate of 27.95%, based on analyst consensus.
When was the latest EPS estimate revision for RVPH?▾
The most recent revision occurred on 2026-05-14, when analysts adjusted the next-year EPS growth estimate from 35.69% to 27.95%.
What sector and industry does Reviva Pharmaceuticals Holdings Inc belong to?▾
Reviva Pharmaceuticals Holdings Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. RVPH appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Reviva Pharmaceuticals Holdings Inc (RVPH) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports